Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study - Summary - MDSpire

Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study

  • September 15, 2025

  • 0 min

Share

Objective:

To correct the name of a co-author in the previously published manuscript.

Key Findings:
  • Correction made to the author list of the original study.
Interpretation:

The correction ensures accurate attribution of authorship in the published research.

Limitations:
Conclusion:

Accurate authorship is crucial for academic integrity and proper citation.

Original Source(s)

Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study

  • September 15, 2025

Related Content

Review Highlights Infectious Diarrhea

The authors emphasize the importance of shared decision-making and reassessing goals of care.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Comparison of Periodic In-person ID Care to Daily Tele-ID Care at a Community Hospital